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Abstract
Background: Various movement disorders can be found in ataxia–telangiectasia (AT), including ataxia, dystonia, chorea, and myoclonus, but myoclonus has
rarely been described as the predominant feature in AT.
Case Report: We report two AT patients with prominent myoclonus, illustrating an unusual presentation of this disorder. Sequencing of the ATM gene in the first
patient revealed a homozygous truncating mutation, c.5908C.T (p.Q1970*) in exon 38 of the ATM gene, which has been previously reported as a founder
mutation in the Costa Rican population.
Discussion: Myoclonus can be a predominant or presenting feature in AT, even without dystonia.
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Introduction
Ataxia–telangiectasia (AT) is an autosomal recessive deoxy-
ribonucleic acid (DNA) repair disorder. Typical clinical features
include ataxia, usually as an early feature, oculomotor apraxia,
telangiectasia, immunodeficiency, and increased risk of malig-
nancies such as leukemia and lymphoma. Although they constitute
the name of this disorder, ataxia and telangiectasias are not always
the main or presenting clinical features. In most cases, ataxia
occurs early around age 2–4 years.1 Telangiectasias are usually
detected several years after the onset of ataxia, but they may be
absent.1
The phenomenology of movement disorders seen in AT is broad,
including ataxia, tremor, chorea, dystonia, and myoclonus. In some
cases, dystonia is more prominent than ataxia. Myoclonus is found in
about 25% of AT patients1 and is often accompanied by dystonia;2
predominant myoclonus is uncommon. Here we report two patients
with myoclonus as a predominant feature of AT, and illustrate the
unusual nature of this presentation.
Written informed consent was obtained from the patients for
publication of this case report and any accompanying videos.
Case report
Patient 1
A Dominican boy presented to our clinic at age 11 (in March 2013),
with a 6-year history of progressive imbalance. Myoclonus of his arms
limited his ability to use his hand to reach or transfer objects, such as
holding utensils or feed himself. On examination, he was wheelchair-
bound, with marked oculomotor apraxia for both vertical and
horizontal eye movements. Head thrusts were required to generate
saccades, and there was a marked delay of saccade initiation and
saccadic hypometria. There were prominent scleral conjunctival
vessels, but no overt telangiectasias in any body regions. Frequent,
irregular myoclonic jerks of his head, trunk, and arms were present,
which became worse with action. It was difficult to evaluate stimulus
sensitivity of myoclonus because of the frequency of the jerks. There
was marked appendicular and limb ataxia, but no dystonia. Hypotonia
in his trunk and extremities was accompanied by decreased reflexes
(Video 1).
Family history was negative, and included an older sister and a
younger brother. There was no history of consanguinity. Laboratory
investigations revealed a markedly elevated alpha-fetoprotein level
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(AFP 624; normal 0–9 ng/ml), and reduced immunoglobulin (Ig)A
level. Given the elevated AFP and oculomotor apraxia, the differential
diagnosis was narrowed down to AT and ataxia with oculomotor
apraxia (AOA) type 2. A routine karyotype was normal without
evidence of translocations. Array comparative genomic hybridization
was normal. Sequencing of the ATM gene revealed a homozygous
truncating mutation, c.5908C.T (p.Q1970*) in exon 38 of the ATM
gene, which has been previously reported as a founder mutation in the
Costa Rican population.3
He was treated with levetiracetam 1,000 mg/day (Video 2) with
mild improvement in myoclonus. The dose was then increased to
1,500 mg/day with moderate improvement in myoclonus, hand
function, and activities of daily living. Abdominal ultrasound did not
reveal evidence of malignancy.
Patient 2
A 12-year-old boy presented for evaluation of jerking movements.
He was first noticed to have hypotonia and unsteadiness when he
started to walk at age 18 months. When he was 2.5 years old, his 17-
month-old brother was noted to have unsteady walking also. AFP at
age 3 years was elevated to 29 ng/ml. He and his brother were
confirmed to have AT by increased X-ray DNA breakage analysis
(2.52 chromosomal abnormalities in the patient; normal 0.08–0.36);
ATM gene analysis was not performed. The patient had a documented
IgA deficiency with low humoral response noted in repeated
vaccinations; however, there were no recurrent infections.
On examination at age 12 (in March 2010), there was prominent
multifocal myoclonus in the limbs and trunk, during both action and at
rest. There was no dystonia. Ocular motor examination revealed
slowing of saccades. There were no telangiectasias. Deep tendon
reflexes were slightly decreased throughout. Toes were downgoing
bilaterally. Appendicular ataxia was prominent, without truncal ataxia.
A video of this patient is not available.
Discussion
We report two patients with AT in whom myoclonus was the
predominant movement disorder. Both patients had prominent axial
and appendicular myoclonic jerks. The differential diagnosis of ataxia
with oculomotor apraxia, as seen in the first patient, includes AT,
AOA1, AOA2, AT-like disorder due to MRE11 mutation,4 and
spinocerebellar ataxia with neuropathy type 1 (SCAN1) due to TDP1
mutation. The elevation of AFP narrowed the differential diagnosis,
and testing confirmed the diagnosis of AT.
DNA breakage due to radiosensitivity can be seen not only in AT
but also in various other DNA repair disorders such as Nijmegen
breakage syndrome, Fanconi anemia, and AT-like disorder due to
MRE11 gene mutations. However, the first two do not have ocular
motor abnormalities, cerebellar ataxia, or neuropathy. Progressive
myoclonic ataxia has recently been reported in AT-like disorder due to
MRE11 mutations,4 but movement disorders have never been reported
in the first two. In MRE11-related AT-like disorder, reduced
immunoglobulin levels and elevated AFP are generally not seen.5
We reviewed the literature of AT patients with myoclonus (Table 1).
Most patients reported previously had both myoclonus and dystonia.
Myoclonus without dystonia as in our patients is much less common.
In previously reported cases, myoclonus involved mainly head or neck
and upper limbs, whereas myoclonus in our patients involved neck,
trunk and all extremities. Although two patients previously reported by
Cummins et al.6 and Nakayama et al.7 were noted to have truncal
extensor dystonia, the phenomenology of the truncal jerking in our
patients is clearly myoclonus.
There has been evidence in the literature suggesting the contribu-
tion of the cerebellum in myoclonus. In AT, the pathological hallmark
is loss of cerebellar Purkinje and granule cells that leads to cerebellar
Videos: Video 1. Examination of the First Patient before the Initiation of
Levetiracetam Revealed Frequent Myoclonic Jerks of the Neck and Trunk at Rest.
Ocular telangiectasia was not present. There were occasional square wave jerks.
Oculomotor apraxia was demonstrated, with marked delay of saccade initiation.
Once he generated saccades, they were hypometric, and saccadic velocities were
slow. Pursuits were relatively preserved compared with saccades. Horizontal and
vertical optokinetic nystagmus was reduced. Myoclonus of bilateral upper
extremities was more prominent with action, such as when he held his arms up or
moved his hand to the target. Video 2. Examination of the First Patient 9 Months
after the Examination in Video 1, when the Patient was on Levetiracetam
1,000 mg/day. Neck and truncal myoclonus was mildly improved. There were
less axial myoclonic jerks at rest. Myoclonus of the neck was more prominent
when he tried to perform tasks such as attempting to move his eyes during the
examination. Oculomotor apraxia and other ocular motility examinations had not
significantly changed since the examination in Video 1. Myoclonus remained
more prominent with action than at rest, but action myoclonus when holding his
arms up or moving his arms had slightly improved since the examination in Video
1. The finger-following test demonstrated not only action myoclonus, but also
symmetric overshoot dysmetria.
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atrophy and degeneration.8 We suggest the possibility that the same
pathological process in the cerebellum leads to myoclonus in AT.
Although electrophysiologic testing was not available in our patients, and
we were unable to determine clear stimulus sensitivity because of the
frequency of the jerks, a cortical origin of the myoclonic jerks was
suspected. Prominent action myoclonus with involvement of the distal
limbs and the response to levetiracetam in the first patient suggests the
possibility of cortical origin. Cerebellar pathology is also known to be
associated with cortical myoclonus in celiac disease9 and familial cortical
myoclonic tremor with epilepsy.10–12 Thus circuitry or networks that link
the cerebellum to the cerebral cortex may give rise to myoclonic jerks.
A Costa Rican founder mutation was found in Patient 1, who is
actually of Dominican descent. Although there are no mutation hot spots
in the ATM gene, founder mutations have been reported in several ethnic
populations including African American, Costa Rican, Iranian, Italian,
Japanese, Polish, and Turkish, among others (but not in Dominican). Six
Costa Rican founder mutations include c.5908C.T (p.Q1970*),
IVS63del17kb, c.7449G.A (p.W2483*), c.4507C.T (p.Q1503*),
c.8264_8268del5 (p.Y2755Cfs*12), and c.1120C.T (p.Q374*) with
c.5908C.T (p.Q1970*) being the most prevalent.3,13 There are no clear
genotype-phenotype correlations for most mutations except for
c.7271T.G, c.8147T.C, and c.8494C.T, which are associated with










Phenomenology Body Regions Involved
Saunders-Pullman et al.14 2012 8 (from 3
families; 3, 1, 4
from each)
Unknown Myoclonus/jerky dystonia Neck in 6 patients, arm(s)
in 4, lower face in 2, upper
face in 1




into slow and fast
movements. The fast
movements were ‘‘similar
to myoclonus or dystonic
jerks’’, but the number of




Cummins et al.6 2013 1 46 Myoclonus and dystonia Head (myoclonus), truncal
extensor muscles
(dystonia)
Me`neret et al.2 2014 12 (out of 14
patients)
Unknown Myoclonus with dystonia
in 10 patients; multifocal
myoclonus without
dystonia in 2
Neck, trunk, upper limbs
Nakayama et al.7 2014 1 8 Myoclonic/dystonic jerks Neck and truncal extensor
muscles
Current cases 2014 2 11 and 12 Myoclonus One in neck, face, trunk
and extremities; the other
in the limbs and trunk
The authors, years the cases were published, number of the patients with myoclonus, the phenomenology described in the literature (note that some also described
dystonia), and the body regions involved are shown in each column.
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milder phenotypes.13 With only one patient, we cannot draw an
association between this founder mutation and the myoclonic phenotype.
The prevalence of myoclonus, especially myoclonus without
dystonia, has not been studied systematically in AT. When clinicians
encounter AT patients with myoclonus along with dystonia, the
diagnosis may be less challenging than when patients present with
predominant myoclonus, as in our cases. Recognition of this particular
phenotype, along with other clues on examination and laboratory
testing, can guide clinicians to the correct diagnosis.
In conclusion, myoclonus can be a predominant or presenting
feature in AT, even without dystonia. It is crucial to recognize this
uncommon phenotype, as patients will need surveillance of immuno-
deficiency and malignancies, as well as measures to lessen accumulat-
ing DNA damage from radiologic exposure and chemotherapeutic
agents.
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